GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (ASX:CUV) » Definitions » Dividends per Share

Clinuvel Pharmaceuticals (ASX:CUV) Dividends per Share : A$0.05 (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Clinuvel Pharmaceuticals Dividends per Share?

Clinuvel Pharmaceuticals's dividends per share for the six months ended in Dec. 2023 was A$0.05. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.05. Its Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.24. As of today, Clinuvel Pharmaceuticals's Dividend Yield % is 0.34%.

Good Sign:

Clinuvel Pharmaceuticals Ltd stock dividend yield is close to 5-year high.

During the past 12 months, Clinuvel Pharmaceuticals's average Dividends Per Share Growth Rate was 25.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 17.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Clinuvel Pharmaceuticals was 17.00% per year. The lowest was 7.70% per year. And the median was 12.35% per year.

For more information regarding to dividend, please check our Dividend Page.


Clinuvel Pharmaceuticals Dividends per Share Historical Data

The historical data trend for Clinuvel Pharmaceuticals's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinuvel Pharmaceuticals Dividends per Share Chart

Clinuvel Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.03 0.03 0.03 0.04

Clinuvel Pharmaceuticals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 - 0.04 - 0.05

Competitive Comparison of Clinuvel Pharmaceuticals's Dividends per Share

For the Biotechnology subindustry, Clinuvel Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinuvel Pharmaceuticals's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clinuvel Pharmaceuticals's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Clinuvel Pharmaceuticals's Dividend Yield % falls into.



Clinuvel Pharmaceuticals Dividends per Share Calculation

Dividends paid to per common share.


Clinuvel Pharmaceuticals  (ASX:CUV) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Clinuvel Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0.05/ 0.212
=0.24

During the past 13 years, the highest Dividend Payout Ratio of Clinuvel Pharmaceuticals was 0.09. The lowest was 0.05. And the median was 0.06.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Clinuvel Pharmaceuticals Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
AUD 0.0502023-09-052023-09-062023-09-20Cash DividendannuallyAUD:AUD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.


Clinuvel Pharmaceuticals's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.05/14.57
=0.34 %

Current Share Price is A$14.57.
Clinuvel Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is A$0.05.

During the past 13 years, the highest Dividend Yield of Clinuvel Pharmaceuticals was 0.34%. The lowest was 0.05%. And the median was 0.11%.

Good Sign:

Clinuvel Pharmaceuticals Ltd stock dividend yield is close to 5-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clinuvel Pharmaceuticals Dividends per Share Related Terms

Thank you for viewing the detailed overview of Clinuvel Pharmaceuticals's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Clinuvel Pharmaceuticals (ASX:CUV) Business Description

Traded in Other Exchanges
Address
535 Bourke Street, Level 11, Melbourne, VIC, AUS, 3000
Clinuvel distributes a single-product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the U.S.

Clinuvel Pharmaceuticals (ASX:CUV) Headlines

No Headlines